A longitudinal study of patients with Parkinson’s disease (ELEP): aims and methodology

Grupo ELEP, P. Martínez-Martín, G. Linazasoro-Cristóbal, J. Kulisevsky, M. Aguilar-Barberà, J. de Pedro-Cuesta, E. Cubo-Delgado, M.J. Forjaz, A. Bergareche, J.C. Martínez-Castrillo, M. Blázquez-Estrada, L. Menéndez-Guisasola, C. Salvador-Aguiar, S. González-González, A. Bayés-Rusiñol, L. Vela, J.J. Balseiro-Gómez, A. Ortega-Moreno, S. García-Muñozguren, B. Frades-Payo, S. Arroyo-Velasco, C. Durán-Herrera, J. Duarte, A. Mendoza-Rodríguez, M.F. Rodríguez-Sanz, L.J. López del Val, J.R. Chacón, J.M. Fernández-García, J. Benito-León, V.M. Campos-Arillo, F. Vivancos-Matellano, A. Rojo, M. Álvarez-Saúco, C. Leiva-Santana, P. Mir, M. Carballo-Cordero, A. Palomino-García, J.A. Burguera, M.J. Catalán, M.R. Luquin-Piudo [REV NEUROL 2006;42:360-365] PMID: 16575773 DOI: OPEN ACCESS
Volumen 42 | Number 06 | Nº of views of the article 5.935 | Nº of PDF downloads 1.395 | Article publication date 16/03/2006
Icono-PDF-OFF Download PDF Castellano Icono-PDF-OFF Download PDF English Citation Search in PubMed
Share in: Facebook Twitter
Go to another issue
ABSTRACT Artículo en español English version
INTRODUCTION AND DEVELOPMENT. Parkinson’s disease (PD) is a chronic and progressive disorder. It produces a significant burden not only for patients, but also for their family and caregivers, with a major socio-economic impact on society. Current knowledge on PD is characterized by scarce information about the evolutionary course of: 1) the non-motor PD features; 2) impact of non-motor PD features on disability and health related quality of life (HRQL) impairment; 3) factors related to disability and HRQL determinants; 4) factors that speed or slow the progression of PD; 5) differential long-term effect of available PD therapeutic schedules and their relationships with disability, complications, and HRQL; and 6) impact of the disease on patients’ caregivers. In addition, heterogeneity in the metric quality of the applied measures and selection bias are frequently found. CONCLUSION. Due to the aforementioned limitations and from a multidimensional perspective, a new longitudinal study in PD is deemed necessary. The longitudinal study of PD patients (ELEP) includes a long-term follow-up of never before sistematically assessed aspects, will allow to increase the global knowledge about PD. KeywordsAssessmentLong-term follow-upMethodsParkinson’s disease CategoriesNeurodegeneraciónTrastornos del movimiento
FULL TEXT Artículo en español English version